167 related articles for article (PubMed ID: 36178661)
1. Identification of Gravida Serum Biomarkers for Noninvasive Prenatal Diagnosis Fetal Congenital Heart Disease.
Xia Y; Cheng L; Duan J; Ma J; Zhang Y
J Cardiovasc Transl Res; 2023 Feb; 16(1):255-266. PubMed ID: 36178661
[TBL] [Abstract][Full Text] [Related]
2. The comprehensive study on the role of POSTN in fetal congenital heart disease and clinical applications.
Xia Y; Chen L; Lu J; Ma J; Zhang Y
J Transl Med; 2023 Dec; 21(1):901. PubMed ID: 38082393
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects.
Chen L; Gu H; Li J; Yang ZY; Sun X; Zhang L; Shan L; Wu L; Wei X; Zhao Y; Ma W; Zhang H; Cao S; Huang T; Miao J; Yuan Z
Sci Rep; 2016 Jan; 6():19248. PubMed ID: 26750556
[TBL] [Abstract][Full Text] [Related]
4. Circulating LncRNAs as Novel, Non-Invasive Biomarkers for Prenatal Detection of Fetal Congenital Heart Defects.
Gu M; Zheng A; Tu W; Zhao J; Li L; Li M; Han S; Hu X; Zhu J; Pan Y; Xu J; Yu Z
Cell Physiol Biochem; 2016; 38(4):1459-71. PubMed ID: 27035723
[TBL] [Abstract][Full Text] [Related]
5. Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defects.
Zhu S; Cao L; Zhu J; Kong L; Jin J; Qian L; Zhu C; Hu X; Li M; Guo X; Han S; Yu Z
Clin Chim Acta; 2013 Sep; 424():66-72. PubMed ID: 23707860
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive prenatal testing for congenital heart disease - cell-free nucleic acid and protein biomarkers in maternal blood.
Biró O; Rigó J; Nagy B
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):1044-1050. PubMed ID: 30078353
[No Abstract] [Full Text] [Related]
7. Clinical study of prenatal ultrasonography combined with T‑box transcription factor 1 as a biomarker for the diagnosis of congenital heart disease.
Guo B; Xiao J; Li L; Wang S; Wang L; Liu S
Mol Med Rep; 2018 May; 17(5):7346-7350. PubMed ID: 29568912
[TBL] [Abstract][Full Text] [Related]
8. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
[No Abstract] [Full Text] [Related]
9. Potential role of "omics" technique in prenatal diagnosis of congenital heart defects.
Chen L; Guan J; Wei Q; Yuan Z; Zhang M
Clin Chim Acta; 2018 Jul; 482():185-190. PubMed ID: 29649453
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of maternal circulating microRNAs as non-invasive biomarkers for prenatal diagnosis of congenital heart defects.
Gu H; Chen L; Xue J; Huang T; Wei X; Liu D; Ma W; Cao S; Yuan Z
Biomed Pharmacother; 2019 Jan; 109():823-830. PubMed ID: 30551536
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics.
Li Y; Sun Y; Yang L; Huang M; Zhang X; Wang X; Guan X; Yang P; Wang Y; Meng L; Zhou R; Zhou X; Luo C; Hu P; Jiang T; Xu Z
Front Cardiovasc Med; 2021; 8():671191. PubMed ID: 34164441
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Fetal Umbilical Cord Blood as a Prenatal Screening Tool for Congenital Heart Disease.
Kong D; Li H; Ren C; Yang W; Zhang Z
Ann Clin Lab Sci; 2021 Sep; 51(5):705-712. PubMed ID: 34686514
[TBL] [Abstract][Full Text] [Related]
13. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias.
Miyoshi T; Hosoda H; Nakai M; Nishimura K; Miyazato M; Kangawa K; Ikeda T; Yoshimatsu J; Minamino N
Am J Obstet Gynecol; 2019 Jan; 220(1):104.e1-104.e15. PubMed ID: 30273582
[TBL] [Abstract][Full Text] [Related]
14. Identification of noninvasive diagnostic biomarkers for ectopic pregnancy using data-independent acquisition (DIA)proteomics: a pilot study.
Ma D; Yang R; Chen Y; Huang Z; Shen Y; He C; Zhao L
Sci Rep; 2022 Nov; 12(1):19992. PubMed ID: 36411308
[TBL] [Abstract][Full Text] [Related]
15. Quantitative label-free proteomic analysis of human follicle fluid to identify novel candidate protein biomarker for endometriosis-associated infertility.
Cao XL; Song JY; Sun ZG
J Proteomics; 2022 Aug; 266():104680. PubMed ID: 35811008
[TBL] [Abstract][Full Text] [Related]
16. Circulating plasma circular RNAs as novel diagnostic biomarkers for congenital heart disease in children.
Wu J; Li J; Liu H; Yin J; Zhang M; Yu Z; Miao H
J Clin Lab Anal; 2019 Nov; 33(9):e22998. PubMed ID: 31429492
[TBL] [Abstract][Full Text] [Related]
17. Impact of maternal social vulnerability and timing of prenatal care on outcome of prenatally detected congenital heart disease.
Perez MT; Bucholz E; Asimacopoulos E; Ferraro AM; Salem SM; Schauer J; Holleman C; Sekhavat S; Tworetzky W; Powell AJ; Sleeper LA; Beroukhim RS
Ultrasound Obstet Gynecol; 2022 Sep; 60(3):346-358. PubMed ID: 35061294
[TBL] [Abstract][Full Text] [Related]
18. 4D DIA-PRM proteomic study identifying modulated pathways and biomarkers associated with pelvic organ prolapse.
Deng W; Zhong Z; Tong Y; Liu J; Wang X; Xu L; Li Y; Chen X; Wei Q; Rao J
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov; 1230():123916. PubMed ID: 37922782
[TBL] [Abstract][Full Text] [Related]
19. Screening of heat stress-related biomarkers in chicken serum through label-free quantitative proteomics.
Liang Q; Huan S; Lin Y; Su Z; Yao X; Li C; Ji Z; Zhang X
Poult Sci; 2024 Feb; 103(2):103340. PubMed ID: 38118221
[TBL] [Abstract][Full Text] [Related]
20. Urinary Proteomics for Noninvasive Prenatal Screening of Trisomy 21: New Biomarker Candidates.
Gao L; Zhang J; Ran X; Jia X; Xing Y; Dai T; Song W; Wu Z; Sun W; Shan D
OMICS; 2021 Nov; 25(11):738-744. PubMed ID: 34714146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
